MB
DGX icon

MidFirst Bank’s Quest Diagnostics DGX Stock Holding History

MidFirst Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
+64
New +$12.6K ﹤0.01% 497
2026
Q1 		– Sell
-7
Closed -$1.22K – 942
2025
Q4 		$1.22K Buy
+7
New +$1.27K ﹤0.01% 698

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

MidFirst Bank's DGX Position: Q2 2026 in Review

MidFirst Bank opened a new position in Quest Diagnostics (DGX) in Q2 2026: 64 shares worth $13.6K. The stake represents ﹤0.01% of the portfolio and ranks #497 among its holdings. This is a return to the name: MidFirst Bank previously reported a position in DGX as recently as Q4 2025.

MidFirst Bank first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 903 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • MidFirst Bank held 64 shares of Quest Diagnostics worth $13.6K as of Q2 2026.
  • Quest Diagnostics was a new MidFirst Bank position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #497 holding.
  • MidFirst Bank first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • 903 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.